F 0684
Provide appropriate treatment and care according to orders, resident’s preferences and goals.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
policy review, interview, and record review, the facility failed to ensure timely provision of medications for 2
of 3 sampled residents, as evidenced by the failure to provide insulin and an antibiotic timely upon Resident
#1's admission to the facility, and failure to provide insulin timely upon Resident #2's admission to the
facility.
Residents Affected - Few
The findings included:
1) Review of the record revealed Resident #1 was admitted to the facility from the hospital on [DATE] at
6:00 PM, with diagnoses to include Type 1 Diabetes. Review of the current Minimum Data Set (MDS)
assessment dated [DATE] documented the resident had a Brief Interview for Mental Status (BIMS) score of
15, on a 0 to 15 scale, indicating he was cognitively intact. This MDS also documented the resident
received both insulin and an antibiotic during the look-back period of 01/28/25 through 02/01/25.
Review of the hospital discharge paperwork documented Resident #1 was to receive insulin, one
short-acting and one long-acting, but the paperwork lacked any specific dose or frequency. Further review
of the discharge paperwork revealed documentation the resident was to receive Zosyn (an antibiotic),
intravenously, every 8 hours.
During an interview on 02/21/25 at 11:21 AM, Resident #1 stated it took a long time to get his insulin, upon
admission to the facility. The resident stated he thought it was because he was admitted to the facility late in
the evening, and they had to get the insulin from an outside pharmacy.
Review of the January 2025 Medication Administration Record (MAR) for Resident #1 revealed the
following:
a) Lantus insulin (long-acting) was ordered to start on 01/29/25 at 6 AM, but was discontinued and not
provided.
b) A sliding scale insulin regimen with Novolog (short-acting) was ordered to start on 01/29/25 at 7:30 AM
with blood sugar checks ordered before each meal and at bedtime but was discontinued and not provided.
This order was then initiated on 01/29/25 at 4:30 PM, missing three opportunities for coverage on 01/28/25
at bedtime, 01/29/25 before breakfast, and on 01/29/25 before lunch. This order was initiated nearly 24
hours after admission to the facility. The resident's blood sugar was high at 335 at that time, with a desired
blood sugar of less than 200.
c) Glargine insulin (long-acting) was not started or provided until 01/29/25 at 4:30 PM, nearly 24
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 2
Event ID:
106075
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
106075
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
02/21/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Garden View Health and Rehabilitation Center
2180 10th Avenue
Vero Beach, FL 32960
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0684
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
hours after admission to the facility. The resident's blood sugar was high at 335 at that time, with a desired
blood sugar of less than 200.
d) The antibiotic Zosyn was ordered to start on 01/29/25 at 6:00 AM. The Zosyn was not administered at
this time, as evidenced by a blank area on the MAR, but started on 01/29/25 at 2 PM, nearly 24 hours after
admission to the facility.
Review of the progress notes lacked any reason for the lack of medication administration.
During a side-by-side record review on 02/21/25, the Assistant Director of Nursing (ADON) confirmed the
lack of insulin dosing from the hospital record. The ADON stated the nurse would have had to call the
physician to get clarification. The ADON stated that sometimes the issue was with which insulin the
insurance would cover, and the pharmacy would then contact the facility for an order to substitute. Upon
further review of the orders, the ADON noted the pharmacy had entered an order for the Novolog FlexPen
to be administered as per the sliding scale on 01/28/25 at 11:35 PM, and the order was not confirmed by
the nursing staff until 01/29/25 at 12:10 PM, fourteen hours later. When asked about the delivery of the
FlexPens, the ADON explained the admission or night nurse should have called the physician to get an
order to use their stock insulin until the pharmacy delivered the FlexPen. Upon further review of the January
2025 MAR, the ADON agreed Resident #1 did not receive any insulin until 01/29/25 at 4:30 PM, nearly 24
hours after the resident was admitted .
During this continued interview, the ADON agreed with the lack of antibiotic administration on 01/29/25 at
6:00 AM. The ADON provided evidence that the Zosyn was available in the facility's stock medications at
the time of the survey, although she was unsure if it was available on 01/29/25.
During the exit conference on 02/21/25 at approximately 4:45 PM, the Director of Nursing (DON) stated she
had reached out to the nurse who should have provided the antibiotic on 01/29/25 at 6 AM, and the nurse
would not confirm if she had provided the medication or not.
2) Review of the record revealed Resident #2 was admitted to the facility on [DATE] at approximately 9:00
PM, with diagnoses to include Diabetes.
Review of the February 2025 MAR for Resident #2 revealed the following:
a) Insulin Asparte (short-acting) was ordered to start on 02/25/25 at 8 AM and not provided.
b) Novolog (short-acting) FlexPen was ordered by the pharmacy (as an insurance approved substitute) on
02/14/25 at 11:35 PM. The order was confirmed by nursing staff on 02/15/25 at 12:14 PM, with the first
dose administered at that time, 15 hours after admission.
c) Insulin Glargine (long-acting) was ordered to start on 02/15/25 at 9 AM and not provided. The pharmacy
placed an order for an insurance approved substitute on 02/14/25 at 11:35 PM. The nursing staff confirmed
the order on 02/15/25 at 12:16 PM, with the first dose administered at 6 PM, 21 hours after admission.
During an interview on 02/21/25 at approximately 4:30 PM, the ADON confirmed the medication delay.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
106075
If continuation sheet
Page 2 of 2